Free Trial
OTCMKTS:EVARF

Lombard Medical (EVARF) Stock Price, News & Analysis

Lombard Medical logo

About Lombard Medical Stock (OTCMKTS:EVARF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lombard Medical was a medical device company focused on the development and commercialization of minimally invasive treatments for abdominal aortic aneurysms (AAAs). Its products were designed for endovascular aneurysm repair (EVAR), a procedure that uses a stent graft to reinforce a weakened section of the aorta and reduce the risk of rupture.

The company’s principal product was the Aorfix AAA stent graft, which was designed to accommodate highly angulated aortas that can be difficult to treat with conventional endovascular devices. Aorfix was supported by a dedicated delivery system and was marketed for use by vascular specialists in selected international markets, including the United States and Europe.

Lombard Medical was based in the United Kingdom and operated internationally through commercial and distribution relationships. The company was acquired by MicroPort Scientific Corporation, after which its business became part of MicroPort’s cardiovascular and endovascular medical-device operations.

AI Generated. May Contain Errors.

Receive EVARF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lombard Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVARF Stock News Headlines

I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
See More Headlines

EVARF Stock Analysis - Frequently Asked Questions

Lombard Medical, Inc. (OTCMKTS:EVARF) posted its earnings results on Thursday, October, 27th. The medical equipment provider reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.11. The medical equipment provider had revenue of $3.04 million for the quarter, compared to analysts' expectations of $3.16 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lombard Medical investors own include Celldex Therapeutics (CLDX), Plus Therapeutics (PSTV), PayPal (PYPL), Can-Fite BioPharma (CANF), Ayala Pharmaceuticals (ADXS), Advanced Micro Devices (AMD) and Athersys (ATHX).

Company Calendar

Today
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:EVARF
Previous Symbol
NASDAQ:EVAR
CIK
N/A
Employees
111
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:EVARF) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners